Oklahoma State University Center for Health Sciences is a public medical school in Tulsa, Oklahoma. It also has a branch campus in Tahlequah, Oklahoma. Founded in 1972, OSU-CHS is part of the Oklahoma State University System.

During the past decade, Oklahoma State University- Center for Health Sciences conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oklahoma State University- Center for Health Sciences" #1 sponsor was "Oklahoma State University Center for Health Sciences" with 5 trials, followed by "Pfizer" with 3 trials sponsored, "Affinivax, Inc." with 2 trials sponsored, "Aziyo Biologics, Inc." with 1 trials sponsored and "Brigham and Women's Hospital" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oklahoma State University- Center for Health Sciences" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Oklahoma State University- Center for Health Sciences" are "Atopic Dermatitis" (2 trials), "Pneumococcal Infections" (2 trials), "Arrhythmias, Cardiac" (1 trials), "Cardiomyopathy" (1 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Oklahoma State University- Center for Health Sciences" in a lesser frequency.

Most popular intervention types in "Oklahoma State University- Center for Health Sciences" are "Biological" (4 trials), "Drug" (4 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "13vPnC" (1 trials), "AFX3772" (1 trials), "ASP3772" (1 trials) and "CanGaroo Envelope" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oklahoma State University- Center for Health Sciences" are 11 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Oklahoma State University- Center for Health Sciences". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Oklahoma State University- Center for Health Sciences, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Oklahoma State University- Center for Health Sciences, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".

Oklahoma State University- Center for Health Sciences has several departments that took part in Clinical trials: "Hardesty Center for Clinical Research and Neuroscience" - 4 trials, "Nutritional Sciences Department, Oklahoma State University" - 2 trials